Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where K.A. Green is active.

Publication


Featured researches published by K.A. Green.


Fertility and Sterility | 2015

Gynecologic health and disease in relation to the microbiome of the female reproductive tract

K.A. Green; Shvetha M. Zarek; William H. Catherino

It is well established that the vagina is colonized by bacteria that serve important roles in homeostasis. Imbalances in the proportion of bacteria may lead to a predisposition to infection or reproductive complications. Molecular-based approaches demonstrated a greater degree of microbial diversity both within and between women than previously recognized. The vaginal microbiome may fluctuate during various states of health, such as during the menstrual cycle or after menopause, and there may be differences in the vaginal microbiome between women of different ethnicities. Furthermore, the specific composition of the vaginal microbiome may influence the predisposition to dysbiosis and the transmission of sexually transmitted infections. An understanding of the diversity of the vaginal microbial environment during states of health is essential for the identification of risk factors for disease and the development of appropriate treatment.


Obstetrics & Gynecology | 2016

A TSH Less Than 2.5 mIU/L in the Pre-Conception Period Does Not Improve Oocyte Quality in Donor IVF [14G]

Caroline R. Juneau; M.D. Werner; Jason Franasiak; K.A. Green; Sara Lubitz; R.T. Scott

INTRODUCTION: Hypothyroidism in pregnancy is associated with miscarriage, preterm delivery, low birth weight, and irreversible cognitive deficits. The American Thyroid Association recommends a pre-conception TSH less than 2.5 mIU/L be maintained to decrease these risks. It has yet to be determined if the benefit of this recommendation is limited to optimizing the gestational environment or if it extends to the oocyte. This analysis seeks to determine if a TSH less than 2.5 mIU/L impacts oocyte quality. METHODS: Euthyroid oocyte donors at a single center from 2002–2014 were included. Patients were divided into 2 groups: group A (TSH less than 2.5 mIU/L) or group B (TSH between 2.5 and 4.5 mIU/L). The number of oocytes retrieved, zygotes formed, and blastocysts formed was compared between groups. Analysis was performed using a students t test. RESULTS: 493 patients had a TSH less than 2.5 mIU/L, and 83 patients had a TSH between 2.5 and 4.5 mIU/L. The mean age of patients was not different between groups (26.7±3.7 vs 26.8±4.0 years, P=.7084). The difference in the number of oocytes retrieved (15.7±7.7 vs 16.3±7.6, P=.5092), zygotes formed (14.2±7.2 vs 14.0±6.8, P=.8249), or blastocysts formed was not statistically significant (5.4±4.1 vs 5.0±4.4, P=.4258). CONCLUSION: Hypothyroidism in pregnancy is associated with significant morbidity. While a TSH less than 2.5 mIU/L in the pre-conception period is recommended, this level does not appear to impact oocyte quality. Clinicians should maintain a TSH less than 2.5 mIU/L knowing its protective effect is likely due to optimization of the gestational environment.


Journal of Assisted Reproduction and Genetics | 2015

Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality

K.A. Green; M.D. Werner; Jason M. Franasiak; Caroline R. Juneau; K.H. Hong; R.T. Scott


Fertility and Sterility | 2018

Cumulus cell transcriptome profiling is not predictive of live birth after in vitro fertilization: a paired analysis of euploid sibling blastocysts

K.A. Green; J.M. Franasiak; M.D. Werner; X. Tao; J. Landis; R.T. Scott; Nathan R. Treff


Fertility and Sterility | 2018

Sperm DNA fragmentation (SDF) index on day of transvaginal oocyte retrieval (TVOR) does not correlate with the incidence of segmental aneuploidy in blastocysts analyzed with targeted next generation sequencing (NGS)

Michael P. Dougherty; S.J. Morin; K.A. Green; J.M. Franasiak; S.A. Neal; A.W. Tiegs; M.D. Werner; R.T. Scott


Fertility and Sterility | 2018

GNRH agonist versus HCG to induce final oocyte maturation in patients at low risk of OHSS

K.A. Green; M.W. Healy; Alan H. DeCherney; A.S. Beall; F.E. Chang; K. Devine; M.J. Hill


Fertility and Sterility | 2017

Sperm DNA fragmentation (SDF) on day of transvaginal oocyte retrieval (TVOR) is associated with semen parameters, though clinical outcomes correlation is unclear

K.A. Green; J.M. Franasiak; C.R. Juneau; S.J. Morin; G. Patounakis; M.D. Werner; R.T. Scott


Fertility and Sterility | 2017

Cost-effectiveness of progesterone (p) luteal support after gonadotropin ovulation induction and intrauterine insemination (GND-IUI)

K.A. Green; B. Perlman; Alan H. DeCherney; M.J. Hill


Fertility and Sterility | 2016

Factors impacting endometrial thickness (EMT) and outcomes in letrozole intrauterine insemination (IUI) cycles

K.A. Green; M.B. Evans; I. Sasson; A.S. Vale; Alan H. DeCherney; K. Devine; E.A. Widra; M.J. Hill


Fertility and Sterility | 2016

Day 3 embryo transfer (ET) versus pushing to day 5 in patients with few embryos

K.A. Green; G. Patounakis; Alan H. DeCherney; J.R. Graham; M.J. Tucker; E.A. Widra; Michael Z. Levy; M.J. Hill

Collaboration


Dive into the K.A. Green's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.M. Franasiak

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan H. DeCherney

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

C.R. Juneau

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

M.J. Hill

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G. Patounakis

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge